NCT04991662View on ClinicalTrials.gov

Effect of Three Weight-adjusted Vasopressors for Elective Cesarean Delivery

PHASE4CompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

October 10, 2021

Primary Completion Date

December 3, 2021

Study Completion Date

December 3, 2021

Conditions
Cesarean Section Complications
Interventions
DRUG

metaraminol

Infusion of metaraminol adjusted according to body weight to obtain higher pH value of fetal umbilical artery blood.

DRUG

Phenylephrine

Infusion of Phenylephrine adjusted according to body weight to obtain higher pH value of fetal umbilical artery blood.

DRUG

Norepinephrine

Infusion of Norepinephrine adjusted according to body weight to obtain higher pH value of fetal umbilical artery blood.

Trial Locations (1)

100000

Department of Anesthesiology and Operating Room, Affiliated Hospital of Peking University People's Hospital, Beijing

All Listed Sponsors
lead

Xuzhou Medical University

OTHER

NCT04991662 - Effect of Three Weight-adjusted Vasopressors for Elective Cesarean Delivery | Biotech Hunter | Biotech Hunter